Holdings
Vivo Capital, LLC
As of Jun 30, 2026, Vivo Capital, LLC reported 46 positions worth US$1.07B. Largest: Trevi Therapeutics, Inc., Praxis Precision Medicines, Inc. and Erasca, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Trevi Therapeutics, Inc. | 5.09M | US$95M | no change | Jun 30, 2026 |
| Praxis Precision Medicines, Inc. | 271K | US$90.8M | −67,779 | Jun 30, 2026 |
| Erasca, Inc. | 4.13M | US$75.6M | −8.02M | Jun 30, 2026 |
| Arrivent Biopharma, Inc. | 1.68M | US$58.4M | +796K | Jun 30, 2026 |
| Abivax Sa | 415K | US$55.3M | +175K | Jun 30, 2026 |
| Tango Therapeutics, Inc. | 1.38M | US$43.1M | −775K | Jun 30, 2026 |
| Corvus Pharmaceuticals, Inc. | 2.81M | US$41.9M | no change | Jun 30, 2026 |
| Bright Minds Biosciences Inc. | 557K | US$39.1M | no change | Jun 30, 2026 |
| Sinovac Biotech, Ltd. | 5.9M | US$38.2M | no change | Jun 30, 2026 |
| Tenax Therapeutics, Inc. | 2.5M | US$36.4M | +2.29M | Jun 30, 2026 |